Uniqure NV (QURE)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $1.53B
Last updated: Nov 17, 2026 at 4:16 PM ET
Uniqure NV (QURE) Statistics
Uniqure NV (QURE) has a market cap of $1.53B and an enterprise value of $1.49B. It kept -1154.84% of revenue as net income over the last 12 months. Its share count is up 19.46% from a year earlier.
Total Valuation
Enterprise value is 3.13% below the market cap, as cash exceeds debt.
| Market Cap | $1.53B |
|---|---|
| Enterprise Value | $1.49B |
| Latest price (Nov 17, 2026) | $20.78 |
Key Dates
| Last Earnings Date | Nov 4, 2026 |
|---|---|
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 72.0x and 4.9x. Its year-end P/S ranged from 1.8x to 383.5x from 2016 to 2025.
| P/S Ratio | 72.0x |
|---|---|
| Forward P/S | 79.6x |
| P/B Ratio | 4.9x |
| P/TBV Ratio | 7.0x |
Price Statistics
The stock is down 30.46% over 52 weeks and trades 27.22% below its 50-day average.
| Beta (1Y) | 0.98 |
|---|---|
| 52-Week Change | -30.46% |
| 1-Month Change | -6.40% |
| 3-Month Change | -57.38% |
| 6-Month Change | -15.84% |
| 5-Year Change | -18.51% |
| 10-Year Change | +265.68% |
| Total Return (1Y) | -30.46% |
| Total Return (3Y CAGR) | +44.47% |
| Total Return (5Y CAGR) | -6.61% |
| Return vs SPY (1Y) | -41.62% |
| Max Drawdown (1Y) | -70.23% |
| Max Drawdown (3Y) | -87.21% |
| Sharpe Ratio (1Y) | -0.29 |
| Correlation with SPY (1Y) | 0.11 |
| 50-Day Average | $28.55 |
| 200-Day Average | $29.62 |
| 52-Week Range | $8.73 to $51.72 |
| RSI (14 Days) | 36.5 |
| Average Volume (20 Days) | 1.94M |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 11.52x current liabilities, and total debt is 0.17x shareholder equity.
| Current Ratio | 11.52x |
|---|---|
| Quick Ratio | 11.52x |
| Debt / Equity | 0.17x |
| Interest Coverage | -3.48x |
Returns and Efficiency
Return on invested capital is -57.88% over the last 12 months, against a 5-year average of -28.69%.
| Return on Equity (ROE) | -79.04% |
|---|---|
| Return on Assets (ROA) | -24.76% |
| Return on Invested Capital (ROIC) | -57.88% |
| Return on Capital Employed (ROCE) | -22.77% |
| ROA (5Y Average) | -16.30% |
| ROIC (5Y Average) | -28.69% |
| Asset Turnover | 0.02x |
| Receivables Turnover | 3.81x |
Scores
QURE has an Altman Z-Score of -0.80, in the distress zone below 1.81, and a Piotroski F-Score of 4 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | -0.80 |
|---|---|
| Altman Z Zone | Distress |
| Piotroski F-Score | 4 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue of $20.17M over the last 12 months is up 28.04% from the 12 months before.
| Revenue | $20.17M |
|---|---|
| Revenue Growth (YoY) | +28.04% |
| Gross Profit | $18.93M |
| Operating Income | -$202.02M |
| Pretax Income | -$233.81M |
| Net Income | -$232.90M |
| EBIT | -$200.47M |
| Reported EPS (TTM) | -$3.30 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 31.33% of the $940.55M in total assets.
| Cash and Equivalents | $98.44M |
|---|---|
| Total Debt | $50.34M |
| Net Cash | $48.10M |
| Net Cash Per Share | $0.69 |
| Working Capital | $632.40M |
| Shareholder Equity | $294.65M |
| Book Value Per Share | $4.22 |
| Tangible Book Value | $208.29M |
| Tangible Book Per Share | $2.98 |
| Total Assets | $940.55M |
| Total Liabilities | $645.90M |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $742.00K of capital spending, operating cash flow left -$192.96M of free cash flow.
| Operating Cash Flow | -$192.22M |
|---|---|
| Capital Expenditures | $742.00K |
| Free Cash Flow | -$192.96M |
| FCF Per Share | -$2.78 |
| Depreciation and Amortization | $34.25M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is -1001.74%.
| Gross Margin | 93.85% |
|---|---|
| Operating Margin | -1001.74% |
| Pretax Margin | -1159.36% |
| Net Margin | -1154.84% |
| EBIT Margin | -994.04% |
| FCF Margin | -956.80% |
| Gross Margin (5Y Average) | 95.70% |
Growth
Revenue fell 46.73% a year over 3 years.
| Revenue Growth (3Y CAGR) | -46.73% |
|---|---|
| Revenue Growth (5Y CAGR) | -15.57% |
| Book Value Per Share Growth (2Y CAGR) | -10.74% |
| Tangible Book Per Share Growth (2Y CAGR) | -16.71% |
Dividends and Yields
QURE does not pay a dividend. Its free cash flow yield is -13.28%.
| FCF Yield | -13.28% |
|---|---|
| Buyback Yield | -0.76% |
| Shareholder Yield | -0.76% |
Peer Position
Against 10 similar companies, QURE has the 2nd highest P/S.
P/S RatioPeer median 6.2x
ROICPeer median -34.36%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +18.42%
| P/S Ratio | 72.0x vs 6.2x median |
|---|---|
| ROIC | -57.88% vs -34.36% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +28.04% vs +18.42% median |
Analyst Forecast
Consensus estimates put revenue growth at 143.34% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +143.34% |
|---|
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About QURE
What is QURE's market cap?
Uniqure NV has a market cap of $1.53B. Its enterprise value, which adds debt and subtracts cash, is $1.49B.
How many shares of QURE are outstanding?
Uniqure NV has 69.90M shares outstanding. The count is up 19.46% from a year earlier.
Does QURE pay a dividend?
No. Uniqure NV does not pay a dividend.
How much debt does QURE have?
Uniqure NV has $50.34M of total debt and $98.44M of cash and equivalents, a net cash position of $48.10M.
QURE pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors